Flyer: digitalMLPA Hereditary Cancer Panels

Many NGS-based techniques struggle to reliably detect CNVs, leaving critical gaps in cancer risk assessment. NXtec Hereditary Cancer Panels offer a powerful solution – providing high-resolution CNV detection with unmatched certainty, even in complex genomic regions.

digitalMLPA integrates into your existing NGS workflow – bringing clarity and confidence to your investigation into hereditary cancer risk across a wide range of cancer types.

This flyer focuses on NXtec D001 Hereditary Cancer Panel 1 and NXtec D002 Hereditary Cancer Panel 2. Learn more about our digitalMLPA technique in this brochure or on this page.